FDA sees room for growth for complex generics
Regulatory NewsJoanne S. Eglovitch
North AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyResearch, Design and DevelopmentRegulatory NewsJoanne S. EglovitchNorth AmericaPharmaceuticalsQuality Assurance and ControlRegulatory Intelligence/PolicyResearch, Design and Development